Pdt Partners, LLC Gritstone Bio, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $293,020 - $618,954	-45,713 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $316,151 - $396,647	-38,887 Reduced 45.97%	45,713 $417,000
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $272,283 - $1.81 Million	66,900 Added 377.97%	84,600 $798,000
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $45,489 - $74,694	17,700 New	17,700 $70,000

37.5M

1.46M

168K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $42.3M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.